Author/Authors :
Jürgen Ruland، نويسنده , , Gordon S Duncan، نويسنده , , Andrew Elia، نويسنده , , Ivan del Barco Barrantes، نويسنده , , Phi Linh Nguyen Thi، نويسنده , , Sue Plyte، نويسنده , , Douglas G Millar، نويسنده , , Denis Bouchard، نويسنده , , Andrew Wakeham، نويسنده , , Pamela S Ohashi، نويسنده , , Tak W Mak، نويسنده ,
Abstract :
Bcl10, a CARD-containing protein identified from the t(1;14)(p22;q32) breakpoint in MALT lymphomas, has been shown to induce apoptosis and activate NF-κ B in vitro. We show that one-third of bcl10−/− embryos developed exencephaly, leading to embryonic lethality. Surprisingly, bcl10−/− cells retained susceptibility to various apoptotic stimuli in vivo and in vitro. However, surviving bcl10−/− mice were severely immunodeficient and bcl10−/− lymphocytes are defective in antigen receptor or PMA/Ionomycin-induced activation. Early tyrosine phosphorylation, MAPK and AP-1 activation, and Ca2+ signaling were normal in mutant lymphocytes, but antigen receptor–induced NF-κ B activation was absent. Thus, Bcl10 functions as a positive regulator of lymphocyte proliferation that specifically connects antigen receptor signaling in B and T cells to NF-κ B activation.
